About Intersect Healthcare Systems
Intersect Healthcare Systems was founded on a simple conviction: the best clinical technology should reduce the burden on providers — not add to it — while extending the reach of the best medicine to every community that needs it.
Our Story
Intersect Healthcare Systems was founded in Gainesville, Florida, at the University of Florida Innovation Hub — in the heart of one of the country's leading academic medical communities. The platform grew from a direct observation: the administrative and documentation burden placed on physicians was robbing patients of time with their providers, and robbing providers of the reason they entered medicine.
The insight came from the inside. Watching a family member practice internal medicine — navigating fragmented systems, redundant documentation, and clinical data that never seemed to be in the right place at the right time — made the problem concrete. If the technology existed to eliminate that friction, why wasn't it being built on the standards that would make it work everywhere?
The answer was to build it from scratch on HL7 FHIR — the interoperability standard that the healthcare industry had finally converged on — and to do it right. Not a legacy system with a FHIR layer. A platform built FHIR-native from the first line of code, capable of growing with the standard as it evolved.
The addition of precision genomics was a natural extension. As genomic medicine moved from research to clinical practice, it became clear that the infrastructure to make it routine — to get genetic findings into the clinical record, to the prescriber, to the community provider — simply did not exist. Intersect was positioned to build it, and the invitation to join HL7 CodeX as a developer in the GenomicX domain confirmed that the approach was right.
Intersect Healthcare Systems is based at the University of Florida Innovation Hub in Gainesville, Florida — embedded in one of the country's leading academic medical and health informatics ecosystems.
The platform was built FHIR-native from the ground up — not migrated from a legacy architecture. Every resource, every workflow, and every API call conforms to the latest HL7 standard. U.S. Patent Pending.
Intersect holds invited membership in the HL7 CodeX FHIR Accelerator — not open enrollment — with active participation in the GenomicX domain's Molecular Tumor Board and Pathogen Genomics workgroups.
Intersect on FHIR™ is pre-commercial and actively seeking clinical validation partners among genomics-forward health systems. Early partners shape the platform and the standards it implements.
What We Believe
Proprietary platforms create lock-in and fragmentation. Building on HL7 FHIR — and contributing to the standards as they are written through CodeX — is the only path to a healthcare system where data flows freely and patients benefit everywhere.
Precision medicine should not be a privilege of geography or wealth. Hereditary cardiovascular risk, pharmacogenomic findings, and cancer predisposition are clinically actionable for every patient — if the infrastructure exists to surface them at the point of care.
The best clinical expertise — academic specialists, genetic counselors, molecular tumor boards — should be accessible to every patient in every community. Remote monitoring, telehealth, and FHIR interoperability are the tools that make this possible.
The Team
The Intersect team brings together health informatics expertise, clinical credentialing, and direct participation in the standards bodies that are shaping the future of healthcare interoperability.
Core team members hold Master of Health Informatics degrees — providing the clinical workflow knowledge and informatics methodology that distinguishes platforms built by clinicians from those built by engineers alone.
Pharmacist-level clinical credentialing informs the pharmacogenomics implementation, drug interaction logic, and medication management workflows — ensuring clinical accuracy at the point of prescribing.
Direct working relationships with molecular tumor board program managers inform the genomics implementation — bridging the gap between the CodeX standards being written in the workgroup and the clinical workflows those standards need to support.
Active workgroup participation in the GenomicX domain means our team is in the room where genomic interoperability standards are being written — contributing to the standards we implement.
Where We've Been. Where We're Going.
Intersect Healthcare Systems founded at the University of Florida Innovation Hub. Development begins on the FHIR-native architecture — built from scratch on HL7 standards, not migrated from legacy code.
Remote patient monitoring, telehealth, clinical decision support, CPOE, and patient mobile application completed. Angular front end upgraded to v17. FastAPI/MongoDB backend deployed on Azure.
Five genomic medicine panels built and live. Full migration to FHIR R6 — the latest HL7 standard — completed across 14 Angular services and 53+ methods. Synthea-generated clinical data set (5,700+ resources) imported for validation.
Accepted as invited Developer/Implementer member of HL7 CodeX. Active participation in GenomicX Molecular Tumor Board and Pathogen Genomics workgroups begins. AI-assisted SOAP note generation and patient self-scheduling completed.
Platform enters clinical validation phase. Actively seeking genomics-forward health system partners for first deployment. Molecular tumor board workflow and ONC certification on the near-term roadmap.
Where We Are
Intersect Healthcare Systems is based at the University of Florida Innovation Hub — one of Florida's leading technology incubators, embedded within the UF Health academic medical center ecosystem in Gainesville.
Cloud-native architecture means no geographic constraints on deployment. Intersect on FHIR™ can serve health systems across the country from a single platform instance — with each client operating their own dedicated deployment on Azure.
Florida's flagship academic medical center ecosystem — providing access to clinical expertise, health informatics research, and the academic medical community that informs everything we build.
Azure-hosted, containerized microservices with no geographic constraints. A single Intersect deployment can serve patients across multiple states and regional service areas.
Initial market focus on Florida, Georgia, Tennessee, North Carolina, and Texas — with national scale as clinical validation and ONC certification milestones are achieved.
Whether you are a health system, a genomics program, or an investor — we want to talk about what Intersect on FHIR™ can do for your organization.
Get in Touch